Table 2.
NT-proBNP levels in patient subgroups by BMI categories
| Subgroup | Lean (n = 138) |
Overweight (n = 72) |
Obese (n = 83) |
p value |
|---|---|---|---|---|
| Age group | ||||
| < 50 |
4528 (2036–5416) |
2837 (2837–2837) |
3310 (470–5402) |
0.779c |
| 50–75 |
4645 (2021–9794) |
3797 (1610–8603) |
2570 (1099–5264) |
0.055c |
| > 75 |
7340 (2534–17018) |
1867 (833–4596) |
3177 (1414–5139) |
0.002c |
| p value | 0.138c | 0.195c | 0.847c | |
| Gender | ||||
| Male |
4528 (1530–11720) |
1869 (1104–3797) |
3202 (1707–5122) |
0.018c |
| Female |
5604 (2712–16785) |
5850 (2363–9308) |
2805 (1099–5237) |
0.009c |
| p value | 0.068d | 0.0017d | 0.912d | |
| Diabetes | ||||
| Yes |
5338 (2419–15086) |
3071 (1540–6801) |
3139 (1262–5264) |
0.0005c |
| No |
4082 (1796–9239) |
3589 (1324–12934) |
4240 (1726–5122) |
0.56c |
| p value | 0.318d | 0.678d | 0.940d | |
| Hypertension | ||||
| Yes |
4812 (1608–13134) |
3693 (1867–10282) |
2805 (914–5122) |
0.04c |
| No |
5352 (2455–15276) |
2623 (1324–5850) |
3189 (1707–5237) |
0.002c |
| p value | 0.478d | 0.226d | 0.497d | |
| LVEF (%) | ||||
| ≤ 40% |
5703 (2712–15727) |
4270 (1869–9308) |
3591 (2164–7127) |
0.039c |
| > 40% |
3427 (1640–10757) |
1867 (636–3776) |
1951 (819–4240) |
0.002c |
| p value | 0.029d | 0.004d | 0.003d | |
| NYHA class | ||||
| II |
3220 (1510–5793) |
2218 (1324–5927) |
1967 (578–3232) |
0.039c |
| III–IV |
8212 (2851–16785) |
3932 (1610–8214) |
4240 (1726–7143) |
0.006c |
| p value | 0.002d | 0.156d | 0.001d | |
BMI body mass index, GFR glomerular filtration rate, LVEF left ventricular ejection fraction, NYHA New York Heart Association
cKruskal‒Wallis test
dMann‒Whitney test